01- Surgeons’ Claim on Low-Risk Patients with Aortic Stenosis Recent randomized trials including low-risk patients showed positive results for transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement. Read more HERE 02- Major Cause of Myocardial Injury by COVID-19 The most common cause of myocardial necrosis in patient undergoing COVID-19 infection is microthrombi. These…
SOLACI PERIPHERAL | 6th Clinical Case: Common, Superficial and Deep Femoral Artery Recanalization
Here is a new SOLACI PERIPHERAL Case! In this opportunity, Dr. Ana Paula Mollón (Arg.) presents “Common, Superficial and Deep Femoral Artery Recanalization”. This is the 6th clinical case presented by SOLACI Peripheral. The purpose of this space is to encourage and further the exchange of experiences and opinions, to keep advancing our knowledge in…
2021 Venezuela Sessions: Clinical Case Contest for Young Interventionists
The Reception of clinical cases ended on 05/11/2021 Tuesday, May 11, 2021. Call for Case Submission XLII SOLACI Regional Sessions – 14th Andean Region. May 26, 27, 28, 2021 – Venezuela Sessions, via Zoom. It is with great pleasure that we hereby invite all young Latin American cardiologists to submit relevant clinical cases related to…
You Are Invited to The Fellow’s Corner 2021
Dear LATAM interventional cardiology fellows, After a long vacation, we are back on track and fully recharged to continue with a ProEducar-SOLACI project called The Fellow’s Corner. For those of you who do not know it, this program aims at providing a forum for interventional cardiologist trainees in LATAM where they can share real-life cases,…
Bulletin 116 ProEducar | Percutaneous Closure of Patent Foramen Ovale
A new edition of the ProEducar Educational Bulletin has arrived for Fellows and interventionists in training. On this occasion, this bulletin addresses in depth the Percutaneous Closure of the Patent Foramen Ovale. Discover the ProEducar Educational Bulletin HERE (spanish version)
Watch again our Webinar on International Women’s Day: Let’s Talk About Gender in Interventional Cardiology
Watch again our Webinar on “International Women’s Day: Let’s Talk About Gender in Interventional Cardiology” on our Youtube account. The event was held on March 8th, 2021, and had the participation of almost 200 people and the support of Boston Scientific. This Webinar was created together with the Argentinian College of Interventional Cardioangiologists and promoted…
LATAMBif Registry: February 2021 Report
The Latin American Registry of Percutaneous Coronary Bifurcations continues to develop at a steady pace. The aim of this prospective multicenter registry is to assess the reality of percutaneous coronary bifurcation to define its needs and establish effective strategies to perfect the daily clinical practice. Bellow you will find data from February 2021, which includes…
Advanced Coronary Imaging Fellowship – McMaster University
We are sharing this invitation to participate in this 1-year training program at McMaster University / Canada. The program aims to develope the following competences Intravascular imaging interpretation. Performance of image-guided complex PCI. Participation in imaging core lab research projects. Applicants should have completed an Interventional Cardiology Fellowship and be independent operators Those who want…
Watch again our Webinar on Left Main PCI and Bifurcations: LATAM Bif Registry
Watch again our Webinar on “Left Main PCI and Bifurcations: LATAM Bif Registry” on our Youtube account. The event was held on March 3rd, 2021, and had the participation of almost 700 people and the support of ABBOTT, Boston Scientific, Medtronic and Terumo. Webinar Contents 00:02 | Introduction – Dr. José Mangione (BRA). 04:58 |…
The Most Read Articles in Interventional Cardiology during February
01- Efficacy of AstraZeneca’s Vaccine against COVID-19 This study, published in the Lancet, looks into the vaccine resulting from the collaboration of the Oxford University and AstraZeneca, among others. Read more HERE 02- Findings on Sputnik V Vaccine Against COVID-19 The Sputnik V vaccine was developed by Gamaleya NRCEM. Similarly to the Oxford-AstraZeneca vaccine, it is based on a viral vector,…
